相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lipid-based nanoparticles in the systemic delivery of siRNA
Qiaoya Lin et al.
NANOMEDICINE (2014)
Anti-angiogenesis in cancer therapy: Hercules and hydra
S. Bellou et al.
CANCER LETTERS (2013)
Cardiovascular complications associated with novel angiogenesis inhibitors: Emerging evidence and evolving perspectives
Steven M. Bair et al.
TRENDS IN CARDIOVASCULAR MEDICINE (2013)
The use of bevacizumab among women with metastatic breast cancer: A survey on clinical practice and the ongoing controversy
Shaheenah Dawood et al.
CANCER (2012)
Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth
Andreas Wicki et al.
CLINICAL CANCER RESEARCH (2012)
Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles
Qiaoya Lin et al.
NANOMEDICINE (2012)
Third generation tyrosine kinase inhibitors and their development in advanced renal cell carcinoma
Ronald M. Bukowski
FRONTIERS IN ONCOLOGY (2012)
Scavenger receptor class B type I: a multifunctional receptor
Giuseppe Valacchi et al.
NUTRITION AND PHYSICAL ACTIVITY IN AGING, OBESITY, AND CANCER (2011)
Biomimetic High Density Lipoprotein Nanoparticles For Nucleic Acid Delivery
Kaylin M. McMahon et al.
NANO LETTERS (2011)
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
Kasey C. Vickers et al.
NATURE CELL BIOLOGY (2011)
Current prospects for RNA interference-based therapies
Beverly L. Davidson et al.
NATURE REVIEWS GENETICS (2011)
Cardiovascular toxicity of anti-angiogenic drugs
Gaetan des Guetz et al.
TARGETED ONCOLOGY (2011)
Targeted Delivery of Small Interfering RNA Using Reconstituted High-Density Lipoprotein Nanoparticles
Mian M. K. Shahzad et al.
NEOPLASIA (2011)
VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management
Hassane Izzedine et al.
EUROPEAN JOURNAL OF CANCER (2010)
Receptor mediated uptake of paclitaxel from a synthetic high density lipoprotein nanocarrier
Linda K. Mooberry et al.
JOURNAL OF DRUG TARGETING (2010)
Knocking down barriers: advances in siRNA delivery (vol 8, pg 129, 2009)
Kathryn A. Whitehead et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
HDL-Mimicking Peptide-Lipid Nanoparticles with Improved Tumor Targeting
Zhihong Zhang et al.
SMALL (2010)
Safety Implications of Vascular Endothelial Growth Factor Blockade for Subjects Receiving Intravitreal Anti-Vascular Endothelial Growth Factor Therapies
Karl Csaky et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2009)
High-Density Lipoprotein Transport Through Aortic Endothelial Cells Involves Scavenger Receptor BI and ATP-Binding Cassette Transporter G1
Lucia Rohrer et al.
CIRCULATION RESEARCH (2009)
Normal Hepatic Cell Surface Localization of the High Density Lipoprotein Receptor, Scavenger Receptor Class B, Type I, Depends on All Four PDZ Domains of PDZK1
Sara A. Fenske et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Inhibition of vascular endothelial growth factor reduces angiogenesis and modulates immune cell infiltration of orthotopic breast cancer xenografts
Christina L. Roland et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells
Meiqing Feng et al.
JOURNAL OF DRUG TARGETING (2008)
The Molecular Basis of Class Side Effects Due to Treatment with Inhibitors of the VEGF/VEGFR Pathway
Jeanine M. Roodhart et al.
CURRENT CLINICAL PHARMACOLOGY (2008)
Mechanisms and optimization of in vivo delivery of lipophilic siRNAs
Christian Wolfrum et al.
NATURE BIOTECHNOLOGY (2007)
Drug insight: advances in renal cell carcinoma and the role of targeted therapies
James M. G. Larkin et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2007)
AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients
Tracy T. Batchelor et al.
CANCER CELL (2007)
Cellular cholesterol homeostasis in vascular endothelial cells
Houssein Hajj Hassan et al.
CANADIAN JOURNAL OF CARDIOLOGY (2006)
Antitumour efficacy of VEGFR2 tyrosine kinase inhibitor correlates with expression of VEGF and its receptor VEGFR2 in tumour models
IK Dev et al.
BRITISH JOURNAL OF CANCER (2004)
Vascular endothelial growth factor as a target for anticancer therapy
N Ferrara
ONCOLOGIST (2004)
VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia
H Gerhardt et al.
JOURNAL OF CELL BIOLOGY (2003)
The role of the high-density lipoprotein receptor SR-BI in the lipid metabolism of endocrine and other tissues
A Rigotti et al.
ENDOCRINE REVIEWS (2003)
Role of angiogenesis in tumor growth and metastasis
J Folkman
SEMINARS IN ONCOLOGY (2002)
分享论文
